$Plasma pentosidine levels are associated with prevalent fractures in patients with chronic liver disease.$

Plasma pentosidine levels are associated with prevalent fractures in patients with chronic liver disease.

<h4>Aim</h4>Osteoporotic fractures negatively impact health-related quality of life and prognosis. Advanced glycation end products (AGEs) impair bone quality and reduce bone strength. The aim of this study was to determine the relationship between plasma levels of pentosidine, a surrogat...

Full description

Bibliographic Details
Main Authors:	Chisato Saeki, Mitsuru Saito, Tomoya Kanai, Masanori Nakano, Tsunekazu Oikawa, Yuichi Torisu, Masayuki Saruta, Akihito Tsubota
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2021-01-01
Series:	PLoS ONE
Online Access:	https://doi.org/10.1371/journal.pone.0249728

Similar Items

Clinical Usefulness of FRAX Score for Predicting Sarcopenia in Patients with Chronic Liver Disease
by: Chisato Saeki, et al.
Published: (2021-09-01)

Clinical characteristics of sarcopenia in patients with alcoholic liver cirrhosis
by: Chisato Saeki, et al.
Published: (2021-07-01)

Low Serum 25-Hydroxyvitamin D Levels Are Related to Frailty and Sarcopenia in Patients with Chronic Liver Disease
by: Chisato Saeki, et al.
Published: (2020-12-01)

Low Serum Branched-chain Amino Acid and Insulin-Like Growth Factor-1 Levels Are Associated with Sarcopenia and Slow Gait Speed in Patients with Liver Cirrhosis
by: Chisato Saeki, et al.
Published: (2020-10-01)

Relationship between Osteosarcopenia and Frailty in Patients with Chronic Liver Disease
by: Chisato Saeki, et al.
Published: (2020-07-01)

Plasma pentosidine as a useful biomarker of sarcopenia, low gait speed, and mortality in patients with cirrhosis
by: Chisato Saeki, et al.
Published: (2023-09-01)

Insulin-like growth factor 1 predicts decompensation and long-term prognosis in patients with compensated cirrhosis
by: Chisato Saeki, et al.
Published: (2023-07-01)

Osteosarcopenia predicts poor survival in patients with cirrhosis: a retrospective study
by: Chisato Saeki, et al.
Published: (2023-06-01)

Prognostic significance of sarcopenia and severe vitamin D deficiency in patients with cirrhosis
by: Chisato Saeki, et al.
Published: (2023-05-01)

The Geriatric Nutritional Risk Index predicts sarcopenia in patients with cirrhosis
by: Chisato Saeki, et al.
Published: (2023-03-01)

Serum Insulin-Like Growth Factor 1 Levels, Facture Risk Assessment Tool Scores and Bone Disorders in Patients with Primary Biliary Cholangitis
by: Chisato Saeki, et al.
Published: (2022-08-01)

Low geriatric nutritional risk index predicts poor prognosis in patients with cirrhosis: a retrospective study
by: Hiroshi Kamioka, et al.
Published: (2023-09-01)

Safety and efficacy of pentazocine–midazolam combination for pain and anxiety relief in radiofrequency ablation therapy for hepatocellular carcinoma
by: Masanori Nakano, et al.
Published: (2022-08-01)

Comparative assessment of sarcopenia using the JSH, AWGS, and EWGSOP2 criteria and the relationship between sarcopenia, osteoporosis, and osteosarcopenia in patients with liver cirrhosis
by: Chisato Saeki, et al.
Published: (2019-12-01)

Pentosidine and carboxymethyl-lysine associate differently with prevalent osteoporotic vertebral fracture and various bone markers
by: Masaki Nakano, et al.
Published: (2020-12-01)

Protein Kinase C Delta Is a Novel Biomarker for Hepatocellular Carcinoma
by: Tsunekazu Oikawa, et al.
Published: (2023-01-01)

Influencing Factors and Molecular Pathogenesis of Sarcopenia and Osteosarcopenia in Chronic Liver Disease
by: Chisato Saeki, et al.
Published: (2021-08-01)

Potential significance of uncovered self‐expandable metal stents for distal malignant biliary obstruction: A propensity score‐adjusted competing risk regression analysis
by: Yuichi Torisu, et al.
Published: (2023-04-01)

Identification of circulating microRNAs as potential biomarkers for hepatic necroinflammation in patients with autoimmune hepatitis
by: Koji Fujita, et al.
Published: (2022-07-01)

Plasma Pentosidine and Its Association with Mortality in Patients with Chronic Kidney Disease.
by: Anna Machowska, et al.
Published: (2016-01-01)

Association of Urinary Pentosidine Levels With the Risk of Fractures in Patients With Severe Osteoporosis: The Japanese Osteoporosis Intervention Trial‐05 (JOINT‐05)
by: Shiro Tanaka, et al.
Published: (2022-10-01)

Hemobilia Derived from Cystic Artery Pseudoaneurysm
by: Takayuki Tanaka, et al.
Published: (2019-02-01)

Serum pentosidine levels in systemic lupus erythematosus
by: Renato Nisihara, et al.
Published: (2021-01-01)

Feasibility of Serum Pentosidine Level as a Potential Risk Factor for Osteoporotic Vertebral Compression Fracture
by: Dong-Hyuk Choi, et al.
Published: (2018-12-01)

Refinement of Biomarker Pentosidine Methodology for use on Aging Birds
by: Crissa K. Cooey, et al.
Published: (2017-02-01)

Glucuronic acid is a novel source of pentosidine, associated with schizophrenia
by: Kazuya Toriumi, et al.
Published: (2023-11-01)

Serum Pentosidine is Associated with Cardiac Dysfunction and Atherosclerosis in T2DM
by: Cao Y, et al.
Published: (2023-01-01)

Non-invasive skin autofluorescence, blood and urine assays of the advanced glycation end product (AGE) pentosidine as an indirect indicator of AGE content in human bone
by: Yoshikuni Kida, et al.
Published: (2019-12-01)

Histological and biochemical evaluation of transforming growth factor-β activation and its clinical significance in patients with chronic liver disease
by: Hiroshi Yokoyama, et al.
Published: (2019-02-01)

Obtaining Pentosidine Levels as an Adjunct to Determine a Patient’s Candidacy for Vertebral Stabilization for a Vertebral Compression Fracture
by: Omar Viswanath, et al.
Published: (2019-04-01)

Dyrk2 gene transfer suppresses hepatocarcinogenesis by promoting the degradation of Myc and Hras
by: Hiroshi Kamioka, et al.
Published: (2023-07-01)

Femur Bone Mineral Density and Pentosidine Level Distinguish Ankylosing Spinal Disorder Patients with and without Sacroiliac Ankylosis
by: Mitsuru Furukawa, et al.
Published: (2020-10-01)

Response to: Obtaining Pentosidine Levels as an Adjunct to Determine a Patient’s Candidacy for Vertebral Stabilization for a Vertebral Compression Fracture
by: Yong-Soo Choi
Published: (2019-04-01)

Total serum pentosidine quantification using liquid chromatography-tandem mass spectrometry
by: Lindsie A. Blencowe, et al.
Published: (2024-03-01)

Elevated Levels of Serum Pentosidine Are Associated with Dropped Head Syndrome in Older Women
by: Yawara Eguchi, et al.
Published: (2019-02-01)

Pentosidine levels in nonproteinuric diabetes associated with both low estimated glomerular filtration rate and cataract
by: Lim XL, et al.
Published: (2012-06-01)

Urine pentosidine levels are negatively associated with trabecular bone score in patients with type 2 diabetes
by: Yong Jun Choi, et al.
Published: (2017-09-01)

Assessment of Pentosidine as a Marker for Advanced Glycation End Products in Type 2 Diabetes Mellitus Patients
by: Sarath Kumar Jaganathan Jaishankar, et al.
Published: (2020-02-01)

Endoscopic ultrasound‐guided fine‐needle biopsy histology with a 22‐gauge Franseen needle and fine‐needle aspiration liquid‐based cytology with a conventional 25‐gauge needle provide comparable diagnostic accuracy in solid pancreatic lesions
by: Yoichi Tomita, et al.
Published: (2021-09-01)

Elevated serum pentosidine is independently associated with the high prevalence of sarcopenia in Chinese middle‐aged and elderly men with type 2 diabetes mellitus
by: Xiaofan Zhang, et al.
Published: (2021-11-01)